Copyright Reports & Markets. All rights reserved.

Global GLP-1R Agonist Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by GLP-1R Agonist Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global GLP-1R Agonist Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Exenatide
    • 1.4.3 Liraglutide
    • 1.4.4 Lixisenatide
    • 1.4.5 Albiglutide
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global GLP-1R Agonist Market Share by Application: 2020 VS 2026
    • 1.5.2 Solid Tumors
    • 1.5.3 Blood-related Tumors
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 GLP-1R Agonist Market Perspective (2015-2026)
  • 2.2 GLP-1R Agonist Growth Trends by Regions
    • 2.2.1 GLP-1R Agonist Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 GLP-1R Agonist Historic Market Share by Regions (2015-2020)
    • 2.2.3 GLP-1R Agonist Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 GLP-1R Agonist Market Growth Strategy
    • 2.3.6 Primary Interviews with Key GLP-1R Agonist Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top GLP-1R Agonist Players by Market Size
    • 3.1.1 Global Top GLP-1R Agonist Players by Revenue (2015-2020)
    • 3.1.2 Global GLP-1R Agonist Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global GLP-1R Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global GLP-1R Agonist Market Concentration Ratio
    • 3.2.1 Global GLP-1R Agonist Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by GLP-1R Agonist Revenue in 2019
  • 3.3 GLP-1R Agonist Key Players Head office and Area Served
  • 3.4 Key Players GLP-1R Agonist Product Solution and Service
  • 3.5 Date of Enter into GLP-1R Agonist Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global GLP-1R Agonist Historic Market Size by Type (2015-2020)
  • 4.2 Global GLP-1R Agonist Forecasted Market Size by Type (2021-2026)

5 GLP-1R Agonist Breakdown Data by Application (2015-2026)

  • 5.1 Global GLP-1R Agonist Market Size by Application (2015-2020)
  • 5.2 Global GLP-1R Agonist Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America GLP-1R Agonist Market Size (2015-2020)
  • 6.2 GLP-1R Agonist Key Players in North America (2019-2020)
  • 6.3 North America GLP-1R Agonist Market Size by Type (2015-2020)
  • 6.4 North America GLP-1R Agonist Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe GLP-1R Agonist Market Size (2015-2020)
  • 7.2 GLP-1R Agonist Key Players in Europe (2019-2020)
  • 7.3 Europe GLP-1R Agonist Market Size by Type (2015-2020)
  • 7.4 Europe GLP-1R Agonist Market Size by Application (2015-2020)

8 China

  • 8.1 China GLP-1R Agonist Market Size (2015-2020)
  • 8.2 GLP-1R Agonist Key Players in China (2019-2020)
  • 8.3 China GLP-1R Agonist Market Size by Type (2015-2020)
  • 8.4 China GLP-1R Agonist Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan GLP-1R Agonist Market Size (2015-2020)
  • 9.2 GLP-1R Agonist Key Players in Japan (2019-2020)
  • 9.3 Japan GLP-1R Agonist Market Size by Type (2015-2020)
  • 9.4 Japan GLP-1R Agonist Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia GLP-1R Agonist Market Size (2015-2020)
  • 10.2 GLP-1R Agonist Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia GLP-1R Agonist Market Size by Type (2015-2020)
  • 10.4 Southeast Asia GLP-1R Agonist Market Size by Application (2015-2020)

11 India

  • 11.1 India GLP-1R Agonist Market Size (2015-2020)
  • 11.2 GLP-1R Agonist Key Players in India (2019-2020)
  • 11.3 India GLP-1R Agonist Market Size by Type (2015-2020)
  • 11.4 India GLP-1R Agonist Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America GLP-1R Agonist Market Size (2015-2020)
  • 12.2 GLP-1R Agonist Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America GLP-1R Agonist Market Size by Type (2015-2020)
  • 12.4 Central & South America GLP-1R Agonist Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GSK
    • 13.1.1 GSK Company Details
    • 13.1.2 GSK Business Overview and Its Total Revenue
    • 13.1.3 GSK GLP-1R Agonist Introduction
    • 13.1.4 GSK Revenue in GLP-1R Agonist Business (2015-2020))
    • 13.1.5 GSK Recent Development
  • 13.2 Novo Nordisk
    • 13.2.1 Novo Nordisk Company Details
    • 13.2.2 Novo Nordisk Business Overview and Its Total Revenue
    • 13.2.3 Novo Nordisk GLP-1R Agonist Introduction
    • 13.2.4 Novo Nordisk Revenue in GLP-1R Agonist Business (2015-2020)
    • 13.2.5 Novo Nordisk Recent Development
  • 13.3 Lily
    • 13.3.1 Lily Company Details
    • 13.3.2 Lily Business Overview and Its Total Revenue
    • 13.3.3 Lily GLP-1R Agonist Introduction
    • 13.3.4 Lily Revenue in GLP-1R Agonist Business (2015-2020)
    • 13.3.5 Lily Recent Development
  • 13.4 Haosoh
    • 13.4.1 Haosoh Company Details
    • 13.4.2 Haosoh Business Overview and Its Total Revenue
    • 13.4.3 Haosoh GLP-1R Agonist Introduction
    • 13.4.4 Haosoh Revenue in GLP-1R Agonist Business (2015-2020)
    • 13.4.5 Haosoh Recent Development
  • 13.5 Sanofi
    • 13.5.1 Sanofi Company Details
    • 13.5.2 Sanofi Business Overview and Its Total Revenue
    • 13.5.3 Sanofi GLP-1R Agonist Introduction
    • 13.5.4 Sanofi Revenue in GLP-1R Agonist Business (2015-2020)
    • 13.5.5 Sanofi Recent Development
  • 13.6 AstraZeneca
    • 13.6.1 AstraZeneca Company Details
    • 13.6.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.6.3 AstraZeneca GLP-1R Agonist Introduction
    • 13.6.4 AstraZeneca Revenue in GLP-1R Agonist Business (2015-2020)
    • 13.6.5 AstraZeneca Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global GLP-1R Agonist status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GLP-1R Agonist development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    GSK
    Novo Nordisk
    Lily
    Haosoh
    Sanofi
    AstraZeneca
    ...

    Market segment by Type, the product can be split into
    Exenatide
    Liraglutide
    Lixisenatide
    Albiglutide
    Others
    Market segment by Application, split into
    Solid Tumors
    Blood-related Tumors

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global GLP-1R Agonist status, future forecast, growth opportunity, key market and key players.
    To present the GLP-1R Agonist development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of GLP-1R Agonist are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now